Physician profile
Alex Senchenkov
NPI 1770558454
$946.19
in general payments reported to CMS, 2019-2025
7 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $129 · 2022: $89.12 · 2023: $99.99 · 2024: $78.58 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Food and Beverage | $178.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $400.00 | 2025 | Eversense |
| Tepha INC | $128.71 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $124.46 | 2019 | |
| Horizon Therapeutics Plc | $99.99 | 2023 | Tepezza |
| Kerecis Limited | $89.12 | 2022 | |
| Ethicon US, LLC | $78.58 | 2024 | Vistaseal, Surgiflo Hemostatic Matrix, Ethicon |
| Integra Lifesciences Corporation | $25.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Senchenkov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.